
CAS 62969-42-0
:Methyl 3-(phenylmethoxy)benzeneacetate
Description:
Methyl 3-(phenylmethoxy)benzeneacetate, identified by its CAS number 62969-42-0, is an organic compound that belongs to the class of esters. It features a methyl ester functional group and is characterized by the presence of a phenylmethoxy group attached to a benzene ring. This compound typically exhibits a moderate to high boiling point and is likely to be a colorless to pale yellow liquid at room temperature. Its molecular structure suggests it may have moderate solubility in organic solvents, while being less soluble in water due to its hydrophobic aromatic components. Methyl 3-(phenylmethoxy)benzeneacetate may possess aromatic properties, contributing to its potential applications in the fragrance and flavor industries. Additionally, it may exhibit biological activity, making it of interest in pharmaceutical research. As with many organic compounds, safety data should be consulted to understand its handling and potential hazards. Overall, this compound's unique structure and properties make it a subject of interest in various chemical applications.
Formula:C16H16O3
InChI:InChI=1S/C16H16O3/c1-18-16(17)11-14-8-5-9-15(10-14)19-12-13-6-3-2-4-7-13/h2-10H,11-12H2,1H3
InChI key:InChIKey=PGBWCJFWJDBDOY-UHFFFAOYSA-N
SMILES:C(C(OC)=O)C1=CC(OCC2=CC=CC=C2)=CC=C1
Synonyms:- Methyl 3-(phenylmethoxy)benzeneacetate
- 3-Benzyloxyphenylacetic acid methyl ester
- Methyl [3-(benzyloxy)phenyl]acetate
- Benzeneacetic acid, 3-(phenylmethoxy)-, methyl ester
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
3-Benzyloxyphenylacetic acid methyl ester
CAS:Formula:C16H16O3Purity:98%Color and Shape:SolidMolecular weight:256.2964Methyl 2-(3-(benzyloxy)phenyl)acetate
CAS:Methyl 2-(3-(benzyloxy)phenyl)acetatePurity:98%Molecular weight:256.3g/molMethyl 2-[3-(benzyloxy)phenyl]acetate
CAS:<p>Methyl 2-[3-(benzyloxy)phenyl]acetate (MBPCA) is a patent-pending lead compound with potential pharmacological applications as an inhibitor of acetyl-coa carboxylase. MBPCA has been shown to reduce plasma triglyceride levels in subchronic studies and is being developed as a potential treatment for hypertriglyceridemia. MBPCA has been shown to be effective against high fat diet-induced obesity, increasing the level of fat oxidation and reducing body weight gain. The pharmacokinetic properties of MBPCA are currently being optimized, including parameters such as bioavailability, volume of distribution, and clearance.</p>Formula:C16H16O3Purity:Min. 95%Molecular weight:256.3 g/mol


